A detailed history of Quadrature Capital LTD transactions in Gh Research PLC stock. As of the latest transaction made, Quadrature Capital LTD holds 31,625 shares of GHRS stock, worth $375,388. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,625
Holding current value
$375,388
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$7.91 - $17.99 $250,153 - $568,933
31,625 New
31,625 $348 Million

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $617M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.